{"id":1148,"date":"2025-01-09T19:17:22","date_gmt":"2025-01-09T19:17:22","guid":{"rendered":"https:\/\/naujienosversle.lt\/index.php\/2025\/01\/09\/moteru-vadovaujama-medtech-mulder-uzdirba-597-tukst-eur-medicinos-prietaisu-atsekamumui-sukurti\/"},"modified":"2025-01-09T19:17:22","modified_gmt":"2025-01-09T19:17:22","slug":"moteru-vadovaujama-medtech-mulder-uzdirba-597-tukst-eur-medicinos-prietaisu-atsekamumui-sukurti","status":"publish","type":"post","link":"https:\/\/naujienosversle.lt\/index.php\/2025\/01\/09\/moteru-vadovaujama-medtech-mulder-uzdirba-597-tukst-eur-medicinos-prietaisu-atsekamumui-sukurti\/","title":{"rendered":"Moter\u0173 vadovaujama medtech Mulder u\u017edirba 597 t\u016bkst. EUR medicinos prietais\u0173 atsekamumui sukurti"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div>\n<p><strong>Mulderis<\/strong>moter\u0173 vadovaujamas ir ma\u017eumai priklausantis medicinos technologij\u0173 SaaS startuolis, \u012fsik\u016br\u0119s Londone, u\u017esitikrino 597 000 EUR per slenkant\u012f i\u0161ankstin\u012f parengimo etap\u0105, kuriam vadovauja SFC Capital, siekdama tobulinti savo blok\u0173 grandin\u0117s technologij\u0105.<\/p>\n<p>\u0160is finansavimo etapas taip pat ap\u0117m\u0117 \u201eInnovate UK\u201c param\u0105 per SMART Grant.<\/p>\n<p>\u0160is finansavimas paspartins Mulderio misij\u0105 siekti skaidrumo ir atitikties<br \/>i\u0161\u0161\u016bkius, kurie apsunkina medicinos prietais\u0173 tiekimo grandin\u0119. Mulderis kuria a<br \/>\u201eBlockchain\u201c varoma platforma, specialiai sukurta MedTech gamintojams, si\u016blanti<br \/>visapusi\u0161ki sprendimai d\u0117l atitikties reikalavimams, at\u0161aukimo valdymo ir visapusi\u0161ki sprendimai<br \/>atsekamumas.<\/p>\n<p>Kalb\u0117damas apie finansavimo etap\u0105, <strong>Michelle Kuei<\/strong>Mulder generalinis direktorius, pa\u017eym\u0117jo, <em>\u201eSFC, kaip m\u016bs\u0173 pirmojo institucinio investuotojo, u\u017etikrinimas yra reik\u0161mingas m\u016bs\u0173 vizijos patvirtinimas. Su j\u0173 parama, kartu su \u201eInnovate UK\u201c parama, esame pasireng\u0119 paspartinti savo pl\u0117tr\u0105, prad\u0117ti bandom\u0105sias programas ir priart\u0117ti prie visi\u0161ko komercinio diegimo.<\/em><\/p>\n<p>2023 m. Michelle Kuei, Sriya Deokar ir Prathyusha Kadivella \u012fkurta vadov\u0173 komanda sujungia sveikatos prie\u017ei\u016bros naujovi\u0173, reguliavimo sistem\u0173 ir technologij\u0173 pl\u0117tros patirt\u012f.<\/p>\n<p>Besivystant reguliavimo aplinkai, Mulderio paleidimas ateina idealiu metu. Nauja<br \/>sistemos, tokios kaip EU MDR ir IVDR, kelia grie\u017etesnius reikalavimus \u012frenginiui<br \/>atsekamumas, prie\u017ei\u016bra po pateikimo rinkai ir kibernetinis saugumas.<\/p>\n<p>Be to, medicinos prietais\u0173 gamybos pa\u017eanga, pvz., AI, daikt\u0173 interneto ir duomen\u0173 analiz\u0117s integravimas tiekimo grandin\u0117s optimizavimui, didina prijungt\u0173, skaidri\u0173 sistem\u0173 paklaus\u0105. \u201eMulder\u201c blok\u0173 grandin\u0117s pagrindu sukurtas sprendimas yra suderintas su \u0161iomis tendencijomis ir suteikia gamintojams \u012frank\u012f, leid\u017eiant\u012f nar\u0161yti \u0161iuolaikin\u0117je sud\u0117tingoje reguliavimo aplinkoje.<\/p>\n<p>Pasak Mulderio, pasaulin\u0117 medicinos prietais\u0173 rinka yra didel\u0117, o bendra adresuojama rinka 2024 m. sudarys 40 milijard\u0173 svar\u0173 sterling\u0173. I\u0161 prad\u017ei\u0173 Mulderis daugiausia d\u0117mesio skirs JK MV\u012e medicinos prietais\u0173 gamintoj\u0173 rinkai. \u0160is strateginis po\u017ei\u016bris bus tarptautin\u0117s pl\u0117tros startas, skirtas JAV, ES, Japonijos, Indijos ir Taivano MV\u012e segmentams.<\/p>\n<p>Kai \u201eMulder\u201c ruo\u0161iasi bandomajam etapui, jis aktyviai bendradarbiauja su pramon\u0117s partneriais, kad dalyvaut\u0173 bandomosiose programose, suteikdamas gamintojams ankstyv\u0105 prieig\u0105 prie savo platformos. 2025 m. prad\u017eioje atidarius antr\u0105j\u0105 i\u0161ankstinio pardavimo ciklo dal\u012f, \u201eMulder\u201c tikisi reik\u0161ming\u0173 gairi\u0173, kurios atvers keli\u0105 augimui ir b\u016bsimam vertinimui.<\/p>\n<p><strong>Niklasas F\u00f6ltzas<\/strong>SFC Capital rinkodaros ir komunikacijos vadovas, pasidalijo savo entuziazmu: \u201e<em>Mulderis vadovauja pertvarkymui medicinos prietais\u0173 pramon\u0117je, <\/em><em>sprend\u017eiant esmin\u012f naujovi\u0173 poreik\u012f \u0161ioje srityje. D\u017eiaugiam\u0117s gal\u0117dami paremti komand\u0105 <\/em><em>savo kelion\u0119 ir tiki, kad jie pakeis pramon\u0117s veikl\u0105<\/em>.<\/p>\n<\/div>\n<p><script>\n        !function(f,b,e,v,n,t,s)\n        {if(f.fbq)return;n=f.fbq=function(){n.callMethod?\n            n.callMethod.apply(n,arguments):n.queue.push(arguments)};\n            if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0';\n            n.queue=();t=b.createElement(e);t.async=!0;\n            t.src=v;s=b.getElementsByTagName(e)(0);\n            s.parentNode.insertBefore(t,s)}(window, document,'script',\n            'https:\/\/connect.facebook.net\/en_US\/fbevents.js');\n        fbq('init', '154586475232058');\n        fbq('track', 'PageView');\n    <\/script><br \/>\n<br \/><br \/>\n<br \/><a href=\"https:\/\/www.eu-startups.com\/2025\/01\/female-led-medtech-mulder-secures-e597k-to-develop-medical-device-traceability\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mulderismoter\u0173 vadovaujamas ir ma\u017eumai priklausantis medicinos technologij\u0173 SaaS startuolis, \u012fsik\u016br\u0119s Londone, u\u017esitikrino 597 000 EUR per slenkant\u012f i\u0161ankstin\u012f parengimo etap\u0105, kuriam vadovauja SFC Capital, siekdama tobulinti savo blok\u0173 grandin\u0117s technologij\u0105. \u0160is finansavimo etapas taip pat ap\u0117m\u0117 \u201eInnovate UK\u201c param\u0105 per SMART Grant. \u0160is finansavimas paspartins Mulderio misij\u0105 siekti skaidrumo ir atitiktiesi\u0161\u0161\u016bkius, kurie apsunkina medicinos prietais\u0173&#8230;<\/p>\n","protected":false},"author":1,"featured_media":1149,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[6],"tags":[2537,107,615,2534,868,2535,2536,314,216,548,2533],"class_list":["post-1148","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-europos-verslo-naujienos","tag-atsekamumui","tag-eur","tag-medicinos","tag-medtech","tag-moteru","tag-mulder","tag-prietaisu","tag-sukurti","tag-tukst","tag-uzdirba","tag-vadovaujama"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/posts\/1148","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/comments?post=1148"}],"version-history":[{"count":0,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/posts\/1148\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/media\/1149"}],"wp:attachment":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/media?parent=1148"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/categories?post=1148"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/tags?post=1148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}